3 articles for “AmpC”

Set a search alert

Research ArticleOpen accessEvery word in the titleDetection of Extended-Spectrum β Lactamases and AmpC β-Lactamase Production in Escherichia coli Causing Urinary Tract Infection among HIV and Non-HIV PatientsPadmavathy Kesavaram, Padma Krishnan, Rajasekaran SikhamaniProblem statement: Opportunistic infections have been documented as a leading cause of morbidity among HIV patients. Gram negative pathogens that elaborate beta-lactamases have been reported to be associated with increased morbidity and mortality, especially amongst immunocompromised patients on intensive care and high-dependency units. The most common mechanism of β-lactam drug resistance in Escherichia coli include ESBL, AmpC production. Approach: In … …Current Research in Medicine, Vol. 2, Issue 1 · 18 Aug 2011 · 7,834 accessesView PDF Cite

Research ArticleOpen accessIn the abstractExtended-Spectrum β-Lactamases Producing Escherichia coli Strains Monitored Over 4 Years in The University Hospital in Košice, SlovakiaViera Lovayová, Lucia Vargová, Mária Nagyová et al.The beta-lactamases with extended spectrum of activity (ESBL) are medically one of the most important group of enzymes. The presented study provides identification and determination of the spectrum of resistance against different and clinically used antimicrobial drugs in the clinical isolates of Escherichia coli. These isolates had their origin in different departments of the University Hospital L. Pasteur in Košice. … …Current Research in Microbiology, Vol. 7, Issue 1 · 16 Jun 2016 · 14,537 accessesView PDF Cite

Research ArticleOpen accessIn the abstractPhenotypic ESBL Detection in Acinetobacter baumannii: A Real ChallengeGeetanjali M. Litake, Vikram S. Ghole, Krishna B. Niphadkar, Suresh G. JoshiClinical Laboratory Standards Institute (CLSI) recommends two-step approach for extended-spectrum-β-lactamase (ESBL) detection which includes the screening of recommended agents and the phenotypic confirmation of ESBL using a combination of screening agent and β-lactamase inhibitor. To investigate this approach, we screened 145 β-lactamase-producing Acinetobacter baumannii isolates for ESBL from tracheal secretions using double disk synergy test (DDST) and phenotypic confirmatory disc … …American Journal of Infectious Diseases, Vol. 11, Issue 3 · 19 Oct 2015 · 7,771 accessesView PDF Cite